Advanced Biomed Inc (ADVB) Shareholder Equity
- 2026-03-31: Common Stock, Value, IssuedUSD $1.38K; Additional Paid in Capital, Common StockUSD $21.62M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $843.78K; Retained Earnings (Accumulated Deficit)USD $-13.25M.
- 2025-12-31: Common Stock, Value, IssuedUSD $21.64K; Additional Paid in Capital, Common StockUSD $21.35M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $874.75K; Retained Earnings (Accumulated Deficit)USD $-12.76M.
- 2025-09-30: Common Stock, Value, IssuedUSD $21.64K; Additional Paid in Capital, Common StockUSD $21.35M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $1.26M; Retained Earnings (Accumulated Deficit)USD $-19.62M.
- 2025-06-30: Common Stock, Value, IssuedUSD $1.08K; Additional Paid in Capital, Common StockUSD $21.37M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $1.34M; Retained Earnings (Accumulated Deficit)USD $-19.23M.
Advanced Biomed Inc Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD |
|---|---|---|---|---|---|
| 2026-03-31 | $1.38K | $21.62M | $843.78K | $-13.25M | $9.21M |
| 2025-12-31 | $21.64K | $21.35M | $874.75K | $-12.76M | $9.48M |
| 2025-09-30 | $21.64K | $21.35M | $1.26M | $-19.62M | $3.00M |
| 2025-06-30 | $1.08K | $21.37M | $1.34M | $-19.23M | $3.48M |
| 2025-03-31 | $21.64K | $21.35M | $1.29M | $-18.53M | $4.13M |
| 2024-12-31 | $20.00K | $16.49M | $1.25M | $-17.15M | $619.03K |
| 2024-09-30 | (m) | (m) | (m) | (m) | $1.09M |
| 2024-06-30 | $20.00K | $16.49M | $1.12M | $-15.97M | $1.66M |
| 2024-03-31 | (m) | (m) | (m) | (m) | $-497.80K |
| 2023-12-31 | (m) | (m) | (m) | (m) | $196.84K |
| 2023-06-30 | (m) | (m) | (m) | (m) | $1.31M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |